Infrastructure development and construction materials supply specialist Raubex may have passed the test. But investors still don’t know what questions were asked.
On June 2, Raubex announced that an independent probe had found “no evidence of any unlawful conduct or ethical impropriety”. The market reacted swiftly; shares surged over 9%. To many, it looked like vindication.
But, arguably, what the company didn’t say matters more than what it did.
There’s been no disclosure of the allegations. Was it a procurement irregularity? Financial misstatement? Executive misconduct? In the absence of specifics, the exoneration feels less like a conclusion and more like an attempt at narrative control — a press release designed to close the story without opening the book.
Raubex received the whistleblower report on April 22. Its financial results, initially scheduled for May 12, were delayed by several weeks. That’s not minor housekeeping — that’s operational disruption.
For a JSE-listed company, such a delay signals a material impact, whether financial, reputational or both. Yet Raubex later said the investigation had “no impact” on the numbers.
So which is it? If the financials were unaffected, why the delay? If the delay was prudent, then the allegations were significant. This contradiction lies at the heart of the investor dilemma: Raubex seeks trust without transparency. In today’s capital markets, that’s not caution, it’s a red flag. Governance is a process, not just an outcome.
To its credit, Raubex commissioned an external investigation. But the lack of disclosure undermines the governance posture it hopes to signal.
Arguably, what the company didn’t say matters more than what it did
There’s no information on the nature of the allegations. No details on the scope of the probe. No identification of the “independent advisers”. Were they legal counsel? Forensic auditors? Governance specialists?
Nor is there any indication of regulatory oversight: did the JSE or the Financial Sector Conduct Authority vet the process? Were findings assessed against forensic standards?
Critically, there’s no mention of the whistleblower’s status — whether protected, validated or dismissed. This is not a trivial omission. The King IV code emphasises the responsibility of governing bodies to ensure that whistleblowers are protected from retaliation and that their concerns are handled with integrity. Silence on this front raises concerns about governance compliance, corporate culture and employee trust.
According to the code, best practice demands transparent disclosure, fair treatment of whistleblowers and demonstrable accountability by the board. Principle 13 explicitly recommends that governing bodies ensure mechanisms are in place for stakeholders to raise concerns, with the assurance that these are investigated independently and addressed transparently. King IV also stresses that the outcome of any such investigation — including the board’s oversight and response — should be communicated in a way that enables stakeholders to make an informed assessment of the organisation’s integrity. By failing to provide these disclosures, Raubex appears to fall short of South Africa’s governance gold standard.
The risks of opaque exonerations are far from hypothetical. In 2015, Steinhoff faced allegations of accounting irregularities in Germany — linked to inflated profits and suspicious third-party transactions. To allay market concerns, the company commissioned a narrow legal review by a reputable firm.
The findings were reassuring on paper: no evidence of wrongdoing. These results were used to downplay red flags, quiet auditors and reassure investors. But critically, the review avoided forensic scrutiny, lacked transparency and focused on compliance rather than substance.
When Steinhoff collapsed in December 2017, a subsequent forensic audit by PwC uncovered more than €6.5bn in fictitious transactions and deliberate obfuscation by senior management. The earlier legal opinion — which had given investors a false sense of assurance — proved dangerously insufficient.
This historical precedent should give current investors pause. It illustrates how legal reviews can create the illusion of control, without truly confronting underlying risk. Raubex’s language of exoneration, lacking detail, carries echoes of Steinhoff’s mistakes — and serves as a reminder that being “cleared” is only credible if the scope, independence and findings are fully disclosed.
That said, Raubex appears operationally sound. Annual earnings came in at 601c a share. Return on invested capital equals about 17%. The forward earnings multiple of 6.4 looks attractive. The R28.2bn order book suggests revenue visibility, with Australian operations offering geographic diversification.
Raubex has done much right. It has navigated sector volatility, expanded internationally and executed with financial discipline.
But governance risk creates a valuation gap. Investors don’t require salacious detail — they need risk classification. Was the issue fraud? Compliance? Control environment? Culture?
Because without that, this stops being fundamental analysis and starts becoming speculative trust. And in a post-Steinhoff market, trust without evidence is not an asset, it’s a liability.
To repair the trust gap, Raubex must first clarify the nature of the allegations — financial, ethical, procedural — and provide full details of the investigation process, including scope, credentials and oversight.
The group also needs to reaffirm whistleblower protection and outline governance enhancements, as well as disclose the status and treatment of the whistleblower — including whether protections were upheld and concerns taken seriously.
This isn’t about reputational self-flagellation. It’s about strategic transparency. When trust is fractured, silence is not protective — it’s punitive.
Overall, Raubex remains a standout in the construction sector — disciplined, diversified and profitable. It deserves serious investor attention. But until it completes the story — not with spin but with substance — the stock may remain discounted.
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.